@misc{indiciaeab2f475e8b11,
  title = {Antibodies to ILT3 abrogate myeloid immunosuppression and enable tumor killing},
  author = {Brandish, P. E. and Palmieri, A. and Ayanoglu, G. and Baker, J. and Bueno, R. and Byford, A. and Caniga, M. and Chappell, C. and Cherwinski, H. and Cua, D. J. and Du, X. and Fayadat-Dilman, L. and Hall, B. E. and Issafras, H. and Joyce-Shaikh, B. and Juan, V. and Levy, R. D. and Loboda, A. and Lunceford, J. and Mieczkowski, C. and Meehl, M. and Qu, Y. and Rosenzweig, M. and Singh, L. and Stivers, P. and Tramontozzi, P. J. and Vermilya, K. and Vroom, K. and Wilson, D. C. and Zhang, C. and Zhang-Hoover, J.},
  year = {2021},
  doi = {10.1101/2021.12.18.472552},
  url = {https://www.biorxiv.org/content/10.1101/2021.12.18.472552v1},
  note = {Source identifier: 10.1101/2021.12.18.472552}
}